David Boyce

Business news, market intelligence, and global industry analysis.

The Latest

What Alamar Biosciences’ (NASDAQ: ALMR) IPO pop says about the next phase of proteomics investing

UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control

Representative image of Tesco PLC’s supermarket and financial performance theme after the retailer reported £3.15bn adjusted operating profit, record free cash flow, and a new £750m share buyback.

Tesco is the UK’s biggest grocer again — and its FY26 results explain exactly why Aldi and Lidl should be paying attention

Representative image of military and commercial vessels near the Strait of Hormuz, illustrating Iran’s renewed control measures after reversing its brief claim that the waterway was fully open to commercial shipping.

Iran reverses Hormuz opening within 24 hours — IRGC fires on tankers as blockade standoff deepens

Is Arthur J. Gallagher & Co. buying growth the smart way? Inside the $183m Tompkins Insurance Agencies acquisition

Arthur J. Gallagher & Co.’s $183 million acquisition of Tompkins Insurance Agencies strengthens its Northeast U.S. footprint. Find out how it fits Gallagher’s growth strategy.

μFR system
αvβ6-integrin
α4β7 integrin
ZYUS Life Sciences
Zyrtec
Zyprexa Zydis
Zynga
Zynext Ventures USA LLC
Zynext Ventures
Zynex

November 3, 2025